Skip to Main Content
SPRIM
  • Consultoría
    • Strategy & Innovation
    • Research & Clinical Services
    • Regulatory & Scientific Affairs
    • Medical Marketing & Engagment
  • SPRIM Ventures
  • Inspiración
    • Noticias y Blog
    • Estudios de caso
    • Publicaciones
  • Acerca de nosotros
    • Liderazgo
    • Localizaciones
  • Localizaciones

Publications

back to all Publications
Publication

Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia

Alimentary Pharmacology and Therapeutics, 2014
H. Perazzo, M. Munteanu, Y. Ngo, P. Lebray, N. Seurat, F. Rutka, M. Couteau, S. Jacqueminet P. Giral, D. Monneret, F. Imbert-Bismut, V. Ratziu, A. Hartemann-Huertier, C. Housset, T. Poynard & for the FLIP Consortium
PubMed: 25186086
DOI: 10.1111/apt.12946
Metabolic Disorders, Noninvasive Tests, Diabetes, Dyslipidemia
SPRIM Logo
  • Consultoría
    • Strategy & Innovation
    • Research & Clinical Services
    • Regulatory & Scientific Affairs
    • Medical Marketing & Engagment
  • Inspiración
    • Noticias y Blog
    • Estudios de caso
    • Publicaciones
  • Acerca de nosotros
    • Liderazgo
    • Localizaciones

© 2023 SPRIM. All Rights Reserved

  • Privacy Policy
  • Terms & Conditions

© 2023 SPRIM. All Rights Reserved